Norinchukin Bank’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47M Buy
24,781
+2,254
+10% +$624K 0.05% 183
2026
Q1
$6.65M Buy
22,527
+56
+0.2% +$16.6K 0.08% 147
2025
Q4
$6.14M Buy
22,471
+1,494
+7% +$406K 0.07% 149
2025
Q3
$5.67M Buy
20,977
+151
+0.7% +$41.1K 0.08% 143
2025
Q2
$5.74M Buy
20,826
+2,026
+11% +$551K 0.09% 143
2025
Q1
$4.99M Buy
18,800
+2,507
+15% +$618K 0.09% 139
2024
Q4
$3.78M Buy
16,293
+1,431
+10% +$329K 0.08% 148
2024
Q3
$3.28M Buy
14,862
+2,107
+17% +$436K 0.08% 150
2024
Q2
$2.51M Sell
12,755
-6
-0% -$1.24K 0.07% 160
2024
Q1
$2.75M Sell
12,761
-176
-1% -$37K 0.08% 147
2023
Q4
$2.72M Sell
12,937
-1,722
-12% -$367K 0.06% 145
2023
Q3
$2.94M Sell
14,659
-21,170
-59% -$4.21M 0.07% 144
2023
Q2
$6.64M Buy
35,829
+17,396
+94% +$3.21M 0.11% 131
2023
Q1
$3.53M Buy
18,433
+570
+3% +$103K 0.07% 164
2022
Q4
$3M Sell
17,863
-4,958
-22% -$862K 0.06% 179
2022
Q3
$4.04M Buy
22,821
+2,886
+14% +$570K 0.08% 153
2022
Q2
$4.08M Buy
19,935
+5,466
+38% +$1.16M 0.08% 149
2022
Q1
$3.44M Buy
14,469
+2,610
+22% +$613K 0.05% 224
2021
Q4
$2.71M Sell
11,859
-184
-2% -$40.5K 0.03% 255
2021
Q3
$2.33M Buy
12,043
+1,103
+10% +$223K 0.03% 268
2021
Q2
$2.33M Sell
10,940
-147
-1% -$31K 0.03% 254
2021
Q1
$2.26M Buy
11,087
+494
+5% +$97.3K 0.03% 254
2020
Q4
$1.93M Sell
10,593
-27
-0.3% -$4.59K 0.03% 258
2020
Q3
$1.78M Buy
10,620
+406
+4% +$68.4K 0.03% 253
2020
Q2
$1.66M Sell
10,214
-346
-3% -$62K 0.03% 252
2020
Q1
$1.83M Sell
10,560
-11,115
-51% -$2.21M 0.04% 193
2019
Q4
$4.35M Sell
21,675
-4,338
-17% -$890K 0.06% 177
2019
Q3
$5.5M Buy
26,013
+830
+3% +$173K 0.08% 161
2019
Q2
$4.89M Sell
25,183
-3,584
-12% -$661K 0.08% 166
2019
Q1
$4.73M Buy
28,767
+251
+0.9% +$44.4K 0.06% 203
2018
Q4
$5.36M Buy
28,516
+3,831
+16% +$707K 0.08% 168
2018
Q3
$4.2M Buy
24,685
+3,476
+16% +$585K 0.06% 177
2018
Q2
$3.48M Buy
21,209
+170
+0.8% +$27.8K 0.05% 180
2018
Q1
$3.4M Buy
21,039
+879
+4% +$140K 0.06% 158
2017
Q4
$2.94M Buy
20,160
+1,932
+11% +$275K 0.05% 172
2017
Q3
$2.47M Sell
18,228
-190
-1% -$24K 0.05% 220
2017
Q2
$2.31M Sell
18,418
-120
-0.6% -$14.4K 0.05% 219
2017
Q1
$2.2M Buy
18,538
+1,204
+7% +$145K 0.05% 214
2016
Q4
$2M Sell
17,334
-8,498
-33% -$946K 0.05% 209
2016
Q3
$2.7M Sell
25,832
-9,494
-27% -$991K 0.06% 145
2016
Q2
$3.44M Sell
35,326
-9,762
-22% -$923K 0.08% 134
2016
Q1
$4.33M Buy
45,088
+6,268
+16% +$570K 0.11% 124
2015
Q4
$3.52M Sell
38,820
-804
-2% -$75.7K 0.09% 130
2015
Q3
$3.67M Buy
39,624
+755
+2% +$71.8K 0.1% 126
2015
Q2
$3.62M Sell
38,869
-882
-2% -$82.3K 0.09% 116
2015
Q1
$3.77M Buy
39,751
+30,187
+316% +$2.8M 0.09% 118
2014
Q4
$848K Buy
9,564
+5,909
+162% +$501K 0.02% 349
2014
Q3
$292K Buy
+3,655
New +$275K 0.01% 438
2014
Q2
Sell
-4,090
Closed -$303K 471
2014
Q1
$303K Buy
4,090
+1,236
+43% +$93.2K 0.01% 421
2013
Q4
$224K Sell
2,854
-21
-0.7% -$1.64K 0.01% 448
2013
Q3
$212K Buy
+2,875
New +$212K 0.01% 442

Other funds holding CME

Norinchukin Bank's CME Position: Q2 2026 in Review

Norinchukin Bank increased its CME Group (CME) stake by 10% in Q2 2026, buying an estimated $624K and bringing the position to 24,781 shares worth $5.47M. The position accounts for 0.05% of the portfolio, ranked #183.

Norinchukin Bank first reported a position in CME in Q3 2013 and has held it in 51 quarters since. The position peaked at $6.65M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Norinchukin Bank held 24,781 shares of CME Group worth $5.47M as of Q2 2026.
  • Norinchukin Bank bought 2,254 CME Group shares in Q2 2026, an estimated $624K.
  • CME Group made up 0.05% of Norinchukin Bank's portfolio in Q2 2026, its #183 holding.
  • Norinchukin Bank first reported a position in CME Group in Q3 2013 and has held it in 51 quarters since.
  • Norinchukin Bank's CME Group position peaked at $6.65M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.